Remdesivir is being evaluated in a trial of 1600 patients over multiple sites. Early data of 150 severe patients from University of Chicago are promising with several being discharged home. The drug is made by Gilead. #coronavirus
Reply to this Note | Reply with MedCent | Notes Linking Here | Derive
Password is unique for each entry and was created on initial posting.